A new gene coding for a cytokine-related protein.

About

Description Cytokines are a diversegroup of multifunctional proteins, secreted by white blood cells and a varietyof other cells in the body, which affect almost every aspect of immunity.Cytokines have been shown to function as: (1) mediators of natural immunity; (2)regulators of lymphocyte activation, growth and differentiation; (3) activatorsof nonspecific inflammatory cells; and (4) stimulators of hematopoiesis. Wellknown cytokines include the interferons, tumor necrosis factor, theinterleukins and the family of colony-stimulating factors (GM-CSF, M-CSF andG-CSF). There has been great interest in this group of molecules over the past40 years, especially as their seminal role in immune modulation has beenelucidated.   Description of the Project: Dr. Vilcek, a recognized world leader in cytokine research, recently discovereda new gene coding for a cytokine-related protein. The gene sequence wasinitially identified from cloned cDNAs obtained from human diploid FS-4fibroblasts stimulated with tumor necrosis factor (TNF). TSG-6 (TSG andTNF-stimulated gene) is a secreted 35KD hyaluronate binding protein that isstructurally related to cartilage link protein, proteoglycan core proteins andthe adhesion receptor CD44. TSG-6 is also induced by IL-1 and LPS. Functionally,TSG-6 appears to be involved in the inflammatory process. High levels of TSG-6have been demonstrated in the synovial fluids of a majority of arthritispatients. The anti-inflammatory role of TSG-6 has recently been demonstrated invivo in a murine acute inflammation model, where administration of TSG-6effectively blocked inflammatory response, comparable to systemic dexamethasonetreatment. TSG-6 forms a stable complex with components of the serine proteaseinhibitor, inter-a-inhibitor. The anti-inflammatory effect ofTNF/Il-1-inducible TSG-6 protein, along with its ability to inhibit proteaseaction through inter-a-inhibitor, suggests that TSG-6 is part of a negativefeedback loop operating through the protease network.   Applications: NYU is seeking an industrial partner to assist the development of this novelcytokine for human diagnostic and therapeutic applications.  

Register for free for full unlimited access to all innovation profiles on LEO

  • Discover articles from some of the world’s brightest minds, or share your thoughts and add one yourself
  • Connect with like-minded individuals and forge valuable relationships and collaboration partners
  • Innovate together, promote your expertise, or showcase your innovations